ANI Pharmaceuticals (ANIP)

[Just the facts maam]

That is interesting, silvr. I don't think we will see an buyout for a while.

If ANIP had secured the CV related patent, then ANIP would likely already have been acquired. Therefore, I see a partnership with a 50/50 split of North American profits and ANIP getting a royalties on Ex-US sales. Unless a three way partnership has been established, then could see a three way distribution of North American profits and ANIP receiving ex-us global royalties from both Merck and AbbVie.

Takeda and Abbott formed TAP (Takeda Abbott Partnership) and was very lucrative for both companies between 1977 and 2008. It sure would be nice to see AbbVie, Merck and ANIP forms a spin off company to drive testosterone growth globally.

TAP

AbbVie's new Chief Commercial Officer, Jeffrey Stewart, got his start with TAP.
Stewart joined Abbott in 1992 as part of TAP, a former U.S. joint venture Abbott had with Takeda. He was Abbott’s vice president of proprietary pharmaceuticals overseeing the U.S. market—while Alban was the senior VP—when the company spun AbbVie off into a separate pure-pharma play.

Stewart CCO

Hard to tell how it will play out, but at least we have front seats.

Nice slow and steady climb recently. Looks like they are walking PPS all the way back to the $50 offering. I expect we will see the real run start when it crosses $50.

JMHO